Not exact matches
The study is needed as prostate cancer treatment technologies have advanced, and as active
surveillance has emerged as an important strategy
for sparing low - risk prostate cancer patients unnecessary
side effects.
Men with low - risk prostate cancer who previously had to choose between aggressive treatment, with the potential
for significant
side effects, and active
surveillance, with the risk of disease progression, may have a new option.